NEW YORK – Insys Therapeutics Inc. filed for bankruptcy protection after agreeing to pay hundreds of millions of dollars to settle a related probe by United States prosecutors over the promotion of its highly addictive opioid painkiller. Court papers filed Monday in Delaware by the drugmaker, whose former executives were convicted of bribing doctors, listed…
Want More Free?
To access 2 more articles, please log in or register for free.
Registered users get access to a limited number of free articles every month.